Your browser doesn't support javascript.
loading
PD-L1 inhibitor-induced worsening of eosinophilic obstructive lung disease successfully rescued with anti-interleukin 5 receptor (IL-5R) therapy.
Wassmer, Flora; Suehs, Carey; Boissin, Clement; Bourdin, Arnaud; Charriot, Jeremy.
Affiliation
  • Wassmer F; Department of Respiratory Diseases, University of Montpellier, CHU Montpellier, Montpellier, France.
  • Suehs C; Department of Respiratory Diseases, University of Montpellier, CHU Montpellier, Montpellier, France; Department of Medical Information, University of Montpellier, CHU Montpellier, Montpellier, France.
  • Boissin C; Department of Respiratory Diseases, University of Montpellier, CHU Montpellier, Montpellier, France.
  • Bourdin A; Department of Respiratory Diseases, University of Montpellier, CHU Montpellier, Montpellier, France; PhyMedExp, University of Montpellier, CNRS, INSERM, CHU Montpellier, Montpellier, France.
  • Charriot J; Department of Respiratory Diseases, University of Montpellier, CHU Montpellier, Montpellier, France; PhyMedExp, University of Montpellier, CNRS, INSERM, CHU Montpellier, Montpellier, France. Electronic address: j-charriot@chu-montpellier.fr.
J Allergy Clin Immunol Pract ; 9(1): 567-569, 2021 01.
Article in En | MEDLINE | ID: mdl-32841747

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Interleukin-5 / Immune Checkpoint Inhibitors / Lung Diseases, Obstructive Limits: Aged / Humans / Male Language: En Journal: J Allergy Clin Immunol Pract Year: 2021 Document type: Article Affiliation country: France Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Interleukin-5 / Immune Checkpoint Inhibitors / Lung Diseases, Obstructive Limits: Aged / Humans / Male Language: En Journal: J Allergy Clin Immunol Pract Year: 2021 Document type: Article Affiliation country: France Country of publication: United States